The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes. 1985

O Kildahl-Andersen, and J Nissen-Meyer

The role of monocyte cytotoxic factor (CF) in cytostasis mediated by lymphokine- and interferon gamma (IFN-gamma)-activated monocytes was investigated. Recombinant IFN-gamma as well as lymphokines enhanced monocyte-mediated cytostasis concomitantly with an increase in monocyte CF content. The incubation of lymphokines with monoclonal antibody against human IFN-gamma inhibited cytostasis mediated by lymphokine-exposed monocytes, indicating that the main monocyte-activating factor in the lymphokine supernatant was IFN-gamma. A neutralizing antiserum raised against purified CF inhibited monocyte-mediated cytostasis in a dose-dependent manner. When CF antiserum was added to monocytes previously exposed to lymphokines treated with a monoclonal antibody against IFN-gamma, all cytostatic activity was completely abrogated. No inhibitory effect on cytostasis was observed with preimmune serum. The results indicate that CF is an effector molecule in cytostasis mediated by lymphokine- or IFN-gamma-activated monocytes.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

O Kildahl-Andersen, and J Nissen-Meyer
December 1988, Journal of immunology (Baltimore, Md. : 1950),
O Kildahl-Andersen, and J Nissen-Meyer
May 1990, Journal of immunology (Baltimore, Md. : 1950),
O Kildahl-Andersen, and J Nissen-Meyer
January 1991, European cytokine network,
O Kildahl-Andersen, and J Nissen-Meyer
June 1988, Journal of immunology (Baltimore, Md. : 1950),
O Kildahl-Andersen, and J Nissen-Meyer
November 1995, Immunological investigations,
O Kildahl-Andersen, and J Nissen-Meyer
October 2022, The Journal of endocrinology,
O Kildahl-Andersen, and J Nissen-Meyer
February 1991, Journal of immunology (Baltimore, Md. : 1950),
O Kildahl-Andersen, and J Nissen-Meyer
February 1999, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!